Company Name | Cellectis |
---|---|
Website | https://www.cellectis.com |
Snippet | Cellectis is pioneering robust first-in-class allogeneic CAR T-cell programs that address multiple unmet cancer needs. These programs were designed with simplicity, availability and cost-effectiveness for patients. |
Type | Société Anonyme |
Founded | 1999 |
Website | cellectis.com |
Industry | Biotechnology, genome engineering, oncology |
Products | Engineered CAR T-cells, TALEN technology |
Traded as | NASDAQ: CLLS, Alternext: ACLS.PA |
Key people | André Choulika (CEO) |
Headquarters | Paris XIIIème (France) |
Cellectis is part of the France company list
Cellectis is part of the Biotechnology company list
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us